Abstract
Targeted protein upregulation by modulating the interaction between a target protein and its E3 ligase is the opposite strategy of targeted protein degradation (PROTAC). In their Research Article (e202300978), Dong-Sup Lee, Seung Bum Park enhanced the cellular STING levels by inhibiting STING-TRIM29 interaction, which activates innate immune responses in the tumor microenvironment and potentiates the immune-oncology treatment by changing COLD to HOT tumor. Thus, targeted protein upregulation can be an alternative drug discovery strategy for undruggable targets.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have